{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:49:20Z","timestamp":1791103760569,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1124\/mol.63.5.1169","type":"journal-article","created":{"date-parts":[[2003,4,14]],"date-time":"2003-04-14T14:53:40Z","timestamp":1050332020000},"page":"1169-1179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Differential Declines in Striatal Nicotinic Receptor Subtype Function after Nigrostriatal Damage in Mice"],"prefix":"10.1016","volume":"63","author":[{"given":"Maryka","family":"Quik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn D.","family":"Sum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Whiteaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"McCallum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Musachio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"Mcintosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan C.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon R.","family":"Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.63.5.1169_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0166-2236(00)01850-6","article-title":"Current advances in Parkinson's disease","volume":"24","author":"Ball","year":"2001","journal-title":"Trends Neurosci"},{"key":"10.1124\/mol.63.5.1169_bib2","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1523\/JNEUROSCI.22-04-01208.2002","article-title":"Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice","volume":"22","author":"Champtiaux","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/mol.63.5.1169_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0006-8993(85)90456-1","article-title":"Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons","volume":"348","author":"Clarke","year":"1985","journal-title":"Brain Res"},{"key":"10.1124\/mol.63.5.1169_bib4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0006-8993(00)03087-0","article-title":"Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra","volume":"888","author":"Costa","year":"2001","journal-title":"Brain Res"},{"key":"10.1124\/mol.63.5.1169_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0891-0618(00)00110-1","article-title":"Nicotinic receptors in human brain: topography and pathology","volume":"20","author":"Court","year":"2000","journal-title":"J Chem Neuroanat"},{"key":"10.1124\/mol.63.5.1169_bib6","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"10.1124\/mol.63.5.1169_bib7","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0306-4522(93)90013-6","article-title":"Spatial organization of patch and matrix compartments in the rat striatum","volume":"57","author":"Desban","year":"1993","journal-title":"Neuroscience"},{"key":"10.1124\/mol.63.5.1169_bib8","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1006\/exnr.1999.7106","article-title":"Nicotine alone and in combination with l-DOPA methyl ester or the D2 agonist N-0923 in MPTP-induced chronic hemiparkinsonian monkeys","volume":"158","author":"Domino","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1124\/mol.63.5.1169_bib9","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1471-4159.1992.tb08322.x","article-title":"Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum","volume":"59","author":"Grady","year":"1992","journal-title":"J Neurochem"},{"key":"10.1124\/mol.63.5.1169_bib10","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1046\/j.1471-4159.1994.62041390.x","article-title":"Desensitization of nicotine-stimulated [3H]dopamine release from mouse striatal synaptosomes","volume":"62","author":"Grady","year":"1994","journal-title":"J Neurochem"},{"key":"10.1124\/mol.63.5.1169_bib11","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1471-4159.2001.00019.x","article-title":"Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum","volume":"76","author":"Grady","year":"2001","journal-title":"J Neurochem"},{"key":"10.1124\/mol.63.5.1169_bib12","first-page":"232","article-title":"Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse","volume":"70","author":"Janson","year":"1992","journal-title":"Clin Investig"},{"key":"10.1124\/mol.63.5.1169_bib13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1748-1716.1988.tb08372.x","article-title":"Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse","volume":"132","author":"Janson","year":"1988","journal-title":"Acta Physiol Scand"},{"key":"10.1124\/mol.63.5.1169_bib14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0306-4522(01)00488-2","article-title":"Stimulation of non-alpha7 nicotinic receptors partially protects dopaminergic neurons from 1-methyl-4-phenylpyridinium-induced toxicity in culture","volume":"109","author":"Jeyarasasingam","year":"2002","journal-title":"Neuroscience"},{"key":"10.1124\/mol.63.5.1169_bib15","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/mol.61.1.230","article-title":"Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in \u03b1-conotoxin MII sites","volume":"61","author":"Kulak","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.63.5.1169_bib16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1124\/jpet.102.039347","article-title":"Declines in different \u03b22* nicotinic receptor populations in monkey striatum after nigrostriatal damage","volume":"303","author":"Kulak","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.63.5.1169_bib17","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1097\/00001756-199908200-00012","article-title":"Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion","volume":"10","author":"le Novere","year":"1999","journal-title":"Neuroreport"},{"key":"10.1124\/mol.63.5.1169_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.63.5.1169_bib19","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0022-3565(24)37839-5","article-title":"Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes","volume":"287","author":"Lu","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.63.5.1169_bib20","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.neuro.22.1.443","article-title":"Presynaptic ionotropic receptors and the control of transmitter release","volume":"22","author":"MacDermott","year":"1999","journal-title":"Annu Rev Neurosci"},{"key":"10.1124\/mol.63.5.1169_bib21","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0022-3565(24)38240-0","article-title":"Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the \u03b22 subunit","volume":"289","author":"Marks","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.63.5.1169_bib22","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1046\/j.1471-4159.1997.68041511.x","article-title":"Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats","volume":"68","author":"Marshall","year":"1997","journal-title":"J Neurochem"},{"key":"10.1124\/mol.63.5.1169_bib23","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0165-6147(99)01379-6","article-title":"Dopamine transporters and neuronal injury","volume":"20","author":"Miller","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.63.5.1169_bib24","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.45.6.1041","article-title":"Cigarette smoking and protection from Parkinson's disease: false association or etiologic clue?","volume":"45","author":"Morens","year":"1995","journal-title":"Neurology"},{"key":"10.1124\/mol.63.5.1169_bib25","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0022-3565(25)12091-0","article-title":"[3H]Epibatidine labels nicotinic receptors in rat brain: an autoradiographic study","volume":"275","author":"Perry","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.63.5.1169_bib26","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1471-4159.2002.00951.x","article-title":"Measuring nicotinic receptors with characteristics of alpha4beta2, alpha3beta2 and alpha3beta4 subtypes in rat tissues by autoradiography","volume":"82","author":"Perry","year":"2002","journal-title":"J Neurochem"},{"key":"10.1124\/mol.63.5.1169_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0306-4522(94)00410-7","article-title":"Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology","volume":"64","author":"Perry","year":"1995","journal-title":"Neuroscience"},{"key":"10.1124\/mol.63.5.1169_bib28","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0161-813X(02)00036-0","article-title":"Nicotine and nicotinic receptors; relevance to Parkinson's disease","volume":"131","author":"Quik","year":"2002","journal-title":"Neurotoxicology"},{"key":"10.1124\/mol.63.5.1169_bib29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/1096-9861(20000911)425:1<58::AID-CNE6>3.0.CO;2-X","article-title":"Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization","volume":"425","author":"Quik","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1124\/mol.63.5.1169_bib30","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1523\/JNEUROSCI.21-15-05494.2001","article-title":"Vulnerability of 125I-\u03b1-conotoxin MII binding sites to nigrostriatal damage in monkey","volume":"21","author":"Quik","year":"2001","journal-title":"J Neurosci"},{"key":"10.1124\/mol.63.5.1169_bib31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0306-4522(02)00106-9","article-title":"Differential nicotinic receptor expression in monkey basal ganglia: effects of nigrostriatal damage","volume":"112","author":"Quik","year":"2002","journal-title":"Neuroscience"},{"key":"10.1124\/mol.63.5.1169_bib32","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/sj.bjp.0703989","article-title":"Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice","volume":"132","author":"Ryan","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.63.5.1169_bib33","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/mds.870130405","article-title":"Effects of SIB-1508Y, a novel neuronal nicotinic acetylcholine receptor agonist, on motor behavior in parkinsonian monkeys","volume":"13","author":"Schneider","year":"1998","journal-title":"Movement Disord"},{"key":"10.1124\/mol.63.5.1169_bib34","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.1471-4159.1984.tb02818.x","article-title":"Presynaptic nicotinic cholinergic receptors labeled by [3H]acetylcholine on catecholamine and serotonin axons in brain","volume":"42","author":"Schwartz","year":"1984","journal-title":"J Neurochem"},{"key":"10.1124\/mol.63.5.1169_bib35","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/S1471-1931(00)00023-9","article-title":"Anatomy of the dopamine system in the basal ganglia","volume":"23","author":"Smith","year":"2000","journal-title":"Trends Neurosci"},{"key":"10.1124\/mol.63.5.1169_bib36","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0028-3908(74)90015-X","article-title":"Effect of nicotine and other drugs on the release of 3H-norepinephrine and 3H-dopamine from rat brain slices","volume":"13","author":"Westfall","year":"1974","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.63.5.1169_bib37","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.22-07-02522.2002","article-title":"Involvement of the \u03b13 subunit in central nicotinic binding populations","volume":"22","author":"Whiteaker","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/mol.63.5.1169_bib38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0166-2236(96)10073-4","article-title":"Presynaptic nicotinic ACh receptors","volume":"20","author":"Wonnacott","year":"1997","journal-title":"Trends Neurosci"},{"key":"10.1124\/mol.63.5.1169_bib39","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/nn769","article-title":"Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum","volume":"4","author":"Zhou","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.1124\/mol.63.5.1169_bib40","doi-asserted-by":"crossref","first-page":"8785","DOI":"10.1523\/JNEUROSCI.22-20-08785.2002","article-title":"Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum","volume":"22","author":"Zoli","year":"2002","journal-title":"J Neurosci"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24058309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24058309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.63.5.1169","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T08:55:42Z","timestamp":1740041742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24058309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["S0026895X24058309"],"URL":"https:\/\/doi.org\/10.1124\/mol.63.5.1169","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Declines in Striatal Nicotinic Receptor Subtype Function after Nigrostriatal Damage in Mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.63.5.1169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2003 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}